cp jaundice chapter vii
TRANSCRIPT
-
7/31/2019 CP Jaundice Chapter VII
1/25
Chapter VII
MEDICAL AND NURSING MANAGEMENT
A. Ideal
Medical Management
Detection
A physical exam is always important in assessing the level of jaundice.
Jaundice first appears on the face, and, as the bilirubin level rises, spreads down
the body. The yellow color is best appreciated in natural light, so doing the exam
by a window is helpful.
Tests that will likely be done include:
Complete blood count
Measurement of levels of specific types of bilirubin
Reticulocyte count
Treatment
Phototherapy Phototherapy (light therapy) is the most common medical
treatment for jaundice in newborns. In most cases, phototherapy is the only
treatment required. It consists of exposing an infant's skin to a special blue light,
which breaks bilirubin down into parts that are easier to eliminate in the stool and
urine. Treatment with phototherapy is successful for most infants.
http://www.righthealth.com/topic/Complete%20blood%20count?as=clink&ac=&afc=3626845248http://www.righthealth.com/topic/Complete%20blood%20count?as=clink&ac=&afc=3626845248http://www.righthealth.com/topic/Complete%20blood%20count?as=clink&ac=&afc=3626845248 -
7/31/2019 CP Jaundice Chapter VII
2/25
Phototherapy is usually done in the hospital, but in select cases, it can be
done in the home if the baby is healthy and at low risk of complications.
Infants undergoing phototherapy should have as much skin exposed to
the light as possible. Infants are usually naked (or wearing only a diaper) in an
open bassinet or warmer, but wear eye patches to protect the eyes. It is
important to ensure that lamps do not generate excessive heat, which could
scald an infant's skin. In some institutions, phototherapy blankets are used.
Phototherapy should be continuous, with breaks only for feeding.
Phototherapy is stopped when bilirubin levels decline to a safe level. It is not
unusual for infants to still appear jaundiced after phototherapy is completed.
Bilirubin levels may rebound 18 to 24 hours after stopping phototherapy,
although this rarely requires further treatment.
- Side effects Phototherapy is very safe, but it can have temporary side
effects, including a skin rash and loose bowel movements. Therefore, the
infant's skin color, body temperature, and number of wet diapers are
closely monitored
Exchange transfusion Exchange transfusion is an emergency
procedure that is done to prevent or minimize bilirubin-related brain damage. The
transfusion replaces an infant's blood with donated blood in an attempt to quickly
lower bilirubin levels. Exchange transfusion may be performed in infants who
32
-
7/31/2019 CP Jaundice Chapter VII
3/25
have not responded to other treatments and who have signs of or are at risk of
bilirubin toxicity.
Nursing Management
Hydration It is important for infants receiving phototherapy to drink
adequate fluids (breast milk or formula) since bilirubin is excreted in urine
and bowel movements. Breastfeeding should continue during
phototherapy, and in some cases, intravenous fluids may be necessary.
Breastfeeding Breastfed infants who are not able to consume enough
breast milk, whose weight loss is excessive, or who are dehydrated may
need extra expressed breast milk or formula. Mothers who supplement
with formula should continue to breastfeed or pump to maintain their milk
supply.
B. Actual
Medical Management
Date & Time Doctors Order Rationale
September 15, 2010
2:15 pm
Wt= 3.1 kg
Pls. admit under my
service (ICU is
possible)
TPR q 4 hours &
record pls.
For management
of neonatal jaundice
For monitoring of
the patients condition
33
-
7/31/2019 CP Jaundice Chapter VII
4/25
Continue
breastfeeding.
Pls. attach lab
results to chart.
Start with D5IMB
500 mL @ 16-17
cc/hr.
Meds:
Ampicillin 150 mg q
12 hours IVTT.
Gentamicin 15 mg
OD IVTT.
and physiologic
status. This serves as
the basis for further
interventions to be
given.
To provide proper
nutrition.
Laboratory results
serve as a basis for
possible diseases
associated with the
patient.
Helps to expand
intravascular volume;
corrects an underlyingimbalance in fluids
and electrolytes, and
compensates the loss
in the body.
To treat infection
To treat infection
34
-
7/31/2019 CP Jaundice Chapter VII
5/25
September 15, 2010
7:05 pm
Pls. maintain temp.
between 36.8-37.2C
under droplight.
Turn pt. to sides
prone & supine
position of 2 hours.
To prevent
increase in
temperature
To prevent
occurrence of bed
sores
September 16, 2010
jaundice
Phototherapy q
12 hours on 12 hours
off
For repeat b1, b2
@ 6:00 am tomorrow
Phototherapy is
one of the treatments
for neonatal jaundice.
To diagnose any
possible problem of
patient.
September 16, 2010
UO- 50 cc
IVF to 120 cc q 6 Increasing IVF will
aid in decreasing fluid
level of patient.
September 17, 2010
10:00 am
7:20 pm
Rebound jaundice after
12 on & off exposure
For continuous
phototherapy
For repeat CBC, B1
and B2 @10:00 am
tomorrow
To treat neonatal
jaundice
To diagnose any
problem related to the
results of the patient.
35
-
7/31/2019 CP Jaundice Chapter VII
6/25
September 17, 2010
4:00 pm
IVF to ff D5IMB @
120 cc q 6 in a
soluset.
Using soluset will
monitor efficiently the
fuid balance f the
patient.
September 18, 2010
10:50 pm
Pls. relay B1, B2 &
CBC result once in.
For the AP to
study the result and
diagnose problems of
the patient.
September 19, 2010
9:00 pm
jaundice
D/C phototherapy
refer for rebound
jaundice.
Resume full
breastfeeding
Vit. K, 1mg IM
Jaundice was
already reduced.
To give proper
nutrition.
To enhance blood
clotting.
September 21, 2010
9:30 am
Complete 1 week
course of antibiotics.
To treat infections.
Management Diagnostic Tests
36
-
7/31/2019 CP Jaundice Chapter VII
7/25
Urine Analysis
Urine Analysis is the chemical analysis of a patient's urine. This laboratory
test evaluates the physical characteristics (color, appearance, odor, opacity and
turbidity) of patients urine. It also determines the specific gravity, presence of
sugar and protein, types and amount of cells and crystals present.
Date: September 15, 2010
Physical Characteristics
Color: Yellow
Appearance: Clear
Reaction: 5.0
Specific gravity: 1.002
Chemical Findings
Sugar: (-)
Protein: (-)
Microscopic Findings
Cells:
Pus cells: 1-2/hpf
RBC:0-1/hpf
Crystals:
Amorphous urates: Few
Interpretation:
Pus cells are identified in the sample urine of the patient. Pus cells
37
-
7/31/2019 CP Jaundice Chapter VII
8/25
indicate a urinary tract infection anywhere from the kidneys to the urethranis
present. Cloudiness in urine may be caused by either pus or chemicals, a
difference determined by simple laboratory tests. Presence of RBC in urine is
due to: glomerular damage, tumors, kidney trauma, urinary tract stones, and
urinary tract infections. Theoretically, no red cells should be found. Common
crystals seen even in healthy patients include calcium oxalate, triple phosphate
crystals and amorphous phosphates.
Nursing Responsibilities:
Explain to significant others how to collect a clean catch specimen of at
least 15 mL.
Obtain a first voided morning specimen if possible.
BLOOD TYPING
There are many RBC factors or types: the ABO group and the Rh factor.
The ABO group contains four blood types: A, B, AB, and O. The Rh factor is
another antigen. People whose RBCs have the Rh antigen are Rh positive; those
without the antigen are Rh negative. The purpose of Blood typing is to determine
what is the patients blood group and type.
38
-
7/31/2019 CP Jaundice Chapter VII
9/25
Interpretation:
After testing the blood for blood typing, patient DongHae has been found
out to be Rh positive. He also belongs in Blood type A group.
HEMATOLOGY
The word hematocrit means "to separate blood", a procedure which is
done following the blood draw through the proper use of a centrifuge. Hematocrit
is the measurement of the percentage of red blood cells in whole blood. It is an
important determinant of anemia (decreased), polycythemia (increased),
dehydration (elevated), increased R.B.C. breakdown in the spleen (decreased),
or possible overhydration (decreased).
Hemoglobin is the main transport of oxygen and carbon dioxide in the
blood. It is composed of globin a group of amino acids that form a protein and
heme which contains iron atoms and imparts the red color to hemoglobin. As with
Hematocrit, it is an important determinant of anemia (decreased), dehydration
39
ABO & Rh BLOOD
GROUP
FORWARD TYPING BLOOD TYPE
A +4 RH(+)
B 0 A
C +4
-
7/31/2019 CP Jaundice Chapter VII
10/25
(increased), polycythemia (increased), poor diet/nutrition, or possibly a
malabsorption problem.
EXAM NAME RESULT UNIT NORMAL VALUES
Hemoglobin 213 g/L 110-150
Hematocrit 64 % 35-47
RBC 7.1 X10^12/L 4.0-5.5
WBC 5.0 X10^9/L 5.1-10
-neutrophils 0.33 0.5-0.65
-lymphocytes 0.5 0.25-0.40
-monocytes 0.12 0.03-0.05
-eusinophils 0.05 0.01-0.03-Platelet Count 250 X10^9/L 150-400
Interpretation:
Patient DongHae has been found to have high hematocrit level of 64, the
normal range is 35-47 %. it usually indicates dehydration, but diminishes if
normal fluid balance is restored. Some other infrequent causes of elevated
hematocrit are lung disease, certain tumors, a disorder of the bone marrow
known as polycythemia rubra vera. A low WBC count (leucopenia) may indicate
bone marrow failure, possibly due to infection, tumor, fibrosis, presence of
cytotoxic substance, collagen-vascular diseases (such as lupus erythematosus,
disease of the liver or spleen), or radiation.
Nursing Responsibilities:
40
-
7/31/2019 CP Jaundice Chapter VII
11/25
Explain to the significant others that the tests are done to detect any
hematologic disorders
Use gloves when collecting and handling all specimens.
Transport the specimen to the laboratory as soon as possible after the
collection.
Do not allow the blood sample to clot, of the results will be invalid. Place
the specimen in a biohazard bag.
BLOOD CHEMISTRY
A byproduct of the breakdown of hemoglobin from red blood cells in the
liver, bilirubin is a good indication of the liver's function. Excreted into the bile,
bilirubin gives the bile its pigmentation. Elevated in liver disease, mononucleosis,
hemolytic anemia, low levels of exposure to the sun and toxic effects to some
drugs, decreased levels are seen in people with an inefficient liver, excessive fat
digestion, and possibly a diet low in nitrogen bearing foods.
EXAM NAME RESULT UNIT NORMAL VALUES
DBIL 0.47 H mg/dL 0-0.2
TBIL 14.93 H mg/dL 0.2-1
Indirect TBIL 14.46 H mg/dL 0.2-0.8
Interpretation:
41
-
7/31/2019 CP Jaundice Chapter VII
12/25
When bilirubin levels are high, the skin and whites of the eyes may appear
yellow (jaundice). Jaundice may be caused by liver disease (hepatitis), blood
disorders (hemolytic anemia), or blockage of the tubes (bile ducts) that allow bile
to pass from the liver to the small intestine. Too much bilirubin
(hyperbilirubinemia) in a newborn baby can cause brain damage (kernicterus),
hearing loss, and problems with the muscles that move the eye, physical
abnormalities, and even death. Therefore, some babies who develop jaundice
may be treated with special lights (phototherapy) or a blood transfusion to lower
their bilirubin levels.
Nursing Responsibilities:
define and explain the test to the significant others
state the specific purpose of the test
explain the procedure
discuss test preparation, procedure, and posttest care
some blood chemistry tests will have specific requirements such as dietary
restrictions or medication restrictions.
CBC PLATELET COUNT
This is done to aid in diagnosing anemia, certain cancers of the blood and
monitor blood loss and infection. Also, to diagnose and/or monitor bleeding and
clotting disorders.
EXAM NAME RESULT NORMAL VALUES
42
-
7/31/2019 CP Jaundice Chapter VII
13/25
WBC Count 12.6 5-10x10 na/L
-segmenters 0.30 0.55-0.65
-lymphocytes 0.58 0.25-0.35
-monocytes 0.08 0.03-0.06
-eosinophil count 0.02 0.02-0.04-basophils 0.02 0.03-0.06
Hemoglobin 180 140-170
Hematocrit 0.54 0.40-0.50
Platelet 345 150-350
Interpretation:
Patient DongHae has been found to have an increased level of White
Blood Cells, which indicates an infection. Hemoglobin level is also slightly
elevated, but can still be considered in normal level.
Therapy
Phototherapy is used as a primary treatment for Neonatal Jaundice and
was used for Patient Baby DongHae until observed jaundice was reduced to near
normal as possible.
Pharmacologic Management
43
-
7/31/2019 CP Jaundice Chapter VII
14/25
Date ordered Name of Drug Dosage/ Order
September 15, 2010
2:15 pm
Ampicillin 150 mg q12 IVTT
Gentamicin 15 mg OD IVTT.
September 16, 2010 Phototherapy q 12 hours on 12
hours off
September 19, 2010
9:00 pm
Vit. K 1 gm, IM
DRUG STUDY
44
-
7/31/2019 CP Jaundice Chapter VII
15/25
Brand Name: Ampicillin
Generic name: Ampicillin Sodium
Classification: Anti-infectives; Penicillin
Indications:
Respiratory tract or skin and skin-structure infections.
GI infections or UTIs.
Bacterial meningitis or septicemia.
Uncomplicated gonorrhea.
To prevent endocarditis in patients having dental, GI, and GU procedures.
Contraindications:
Contraindicated in patient hypersensitive to drug or other penicillins.
Use cautiously in patient with other drug allergies (especially to
cephalosporins) because of possible cross-sensitivity, and in those with
mononucleosis because of high risk of maculopapular rash.
Dosage: 150 mg q120 IVTT
Mechanism of Action: inhibits cell-wall synthesis during bacterial multiplication.
Adverse Reactions:
CNS: lethargy, hallucinations, seizures, anxiety, confusion, agitation, depression,
dizziness and fatigue.
CV: vein irritation, thrombophlebitis
GI: diarrhea, nausea and vomiting, abdominal pain, glossitis, stomatitis, gastritis,
enterocolitis, pseudomembranous colitis, black hairy tongue.
45
-
7/31/2019 CP Jaundice Chapter VII
16/25
GU: intestinal nephritis, nephropathy,vaginitis
HEMATOLOGIC: anemia, thrombocytopenia, thrombocytopenic, purpura,
eosinophilia, leukopenia, hemolytic anemia, agranulocytosis.
SKIN: pain at injection site.
OTHER: hypersensitivity reactions, overgrowth of nonsusceptible organisms.
Nursing Responsibilities with Rationale:
Assess patient about allergic reactions to penicillin. This is to prevent
causing adverse reactions such as hypersensitivity.
Obtain specimen for culture and sensitivity test before giving first dose.
This is to identify if correct treatment has been initiated.
Assess for any ampicillin rashes; a dull, red, itchy, flat or raised rashes.
These signs and symptoms may indicate allergic reaction and need to
stop the therapy.
Assess sodium level because each gram of ampicillin contains 2.9 mEq of
sodium.
Assess for the adverse reactions that may occur. This is to prevent the
casualties to worsen.
Health Teaching:
Instruct patient to report adverse reactions promptly.
Tell patient to report discomfort at I.V. injection site.
Advise patient to notify prescriber if a rash, fever, chills develops.
Rationale: To treat infection
46
-
7/31/2019 CP Jaundice Chapter VII
17/25
Brand Name: Gentamicin
Generic name: Gentamicin Sulfate
Classification: Antibiotics; Aminoglyscoside
Indications:
Serious infections caused by sensitive
strains of Pseudomonas aeruginosa, Escherichia coli, Proteus Klebsiella,
or Straphylococcus.
To prevent endocarditis before GI or GU procedure or surgery.
Contraindications:
Contraindicated to patients hypersensitive to drug or other
aminoglycosides..
Use cautiously in neonates, infants, elderly patients, and patient with
impaired renal function or neuromuscular disorder.
Dosage: 15 mg q80 IVTT
Mechanism of Action: inhibits protein synthesis by binding directly to 30S
ribosomal subunits; bactericidal.
Adverse Reactions:
CNS: dizziness, fever, headache, lethargy, encephalopathy, confusion, seizure,
numbness, peripheral neuropathy, vertigo, ataxia, tingling.
CV: hypotension
GI: nausea and vomiting
GU: nephrotoxicity, possible increase in urinary excretion of casts.
47
-
7/31/2019 CP Jaundice Chapter VII
18/25
HEMATOLOGIC: eosinophilia, anemia, leukopenic, thrombocytopenia,
agranulocytosis.
MUSCULOSKELETAL: muscle twitching, myasthenia gravis-like sybdrome.
SKIN: rash, urticaria, pruritus, injection site pain.
OTHER: anaphylaxis
Nursing Responsibilities with Rationale:
Obtain specimen for culture and sensitivity test before giving first dose.
This is to identify if correct treatment has been initiated.
Assess for sign and symptoms of superinfections(especially of upper
respiratory tract), such as continued fever, chills and increased pulse rate.
Signs of superinfection may indicate resistance to drug.
Assess for anaphylaxis: rash, urticaria, pruritius, chills, fever or joint pains.
These signs and symptoms may indicate allergic reaction and need to
stop the therapy.
Assess renal function before and during therapy: urine output, BUN, andcreatinine, monitor for nephrotoxicity.
Health Teaching:
Instruct patient to report adverse reactions promptly report adverse
reactions, such as dizziness, vertigo,tingling or muscle twitching.
Tell patient to report discomfort at I.V. injection site.
Advise patient to notify prescriber if a rash develops or if Signs &
Symptoms of superinfection occur.
Rationale: To treat infection
48
-
7/31/2019 CP Jaundice Chapter VII
19/25
Brand Name: Vitamin K
Generic name: Phytonadione
Classification: Antihemorrhagic
Indications:
Recommended Dietary Allowance
Hypoprothrombinemia caused by vitamin K malabsorption, drug therapy,
or excessive vitamin A dosage.
Hypoprothrombinemia caused by effect of oral anti coagulants.
Contraindications:
Contraindicated to patients hypersensitive to drug.
Dosage: 1 mg IM
Mechanism of Action: an antihemorrhagic factor that promotes hepatic formation
of active coagulation factors.
Adverse Reactions:
CNS: dizziness
CV: flushing, transient hypotension after I.V administration, rapid and weak
pulse.
SKIN: diaphoresis, erythema
OTHER: anaphylaxis or anaphylactoid reactions, usually after excessively raid
I.V administration; pain, swelling, and hematoma at injection site.
Nursing Responsibilities with Rationale:
49
-
7/31/2019 CP Jaundice Chapter VII
20/25
Assess the label for administration route restriction.
For I.M. use in adult and children, give in outer thigh or deltoid region.
Subcutaneous route is preferred to avoid hematoma formation.
With I.M or subcutaneous use, allergic reaction may occur.
Monitor PT and INR to determine dosage effectiveness.
If sever bleeding occur give fresh frozen plasma or whole blood
immediately
Watch for flashing, weakness, tachycardia, and hypertension; condition
may progress to shock.
For hemorrhagic disease in infants, phytonadione cause less adverse
reaction that other vitamin K analogue.
Health Teaching:
Explain the purpose of the drug.
Rationale: To prevent hemorrhagic disease of newborn.
Nursing Management
Encouraged the mother to continue breastfeeding Baby DongHae since
bilirubin is excreted in urine and bowel movements. Breastfeeding should
continue during phototherapy, and in some cases, intravenous fluids may
be necessary.
50
-
7/31/2019 CP Jaundice Chapter VII
21/25
Monitored closely the patient especially the infant's skin color, body
temperature, and number of wet diapers because phototherapy has side
effects like loose bowel movement and skin rashes.
Encouraged the mother to always secure Baby DongHae for his safety.
Advised the significant others to follow and comply with the prescribed
medication.
PROGNOSIS
51
-
7/31/2019 CP Jaundice Chapter VII
22/25
The patients prognosis is fair because they were only able to seek
medical assistance after 7 days. For most babies, jaundice usually resolves
without treatment within 1 to 2 weeks. However, the parents were willing to
comply for any treatment that will be given by the physician.
52
Poor
Fair Good Justification
Duration of
Illness
The patient manifested neonatal jaundice3 days after his birth; however, they seek
for medical assistance only after 7 days.
Onset The manifestation only took place 3 days
after.
PrecipitatingFactors
It is good since there is no involvement ofany risk factor except that it is found to bea normal process happening on newborn.
Willingness toCompliance of
Treatment
The patients mother is willing to complywith the treatment for the recovery of herson, thats why she follows what the
physician is instructing her.
Age
His condition is common to almost 50% ofthe newborn and Baby DongHae is notaware of this because that he is stillyoung.
Environment
His parents see to it that his room isalways clean. However, external factorscan contribute in making it to be not totallyclean.
Family Support
Support system from his family is good
since they show their love and care forBaby DongHae by always securing hissafety.
-
7/31/2019 CP Jaundice Chapter VII
23/25
Discharge Planning
General Condition of client upon discharge
Upon discharge, the patient was lying and sleeping on his crib with her
mother and other significant others around ready to be instructed with home
instructions for the full recovery and improvement of the health status of Baby
DongHae given by the student nurse.
Method
- Instructed the significant others to take the following home
medication as ordered by the physician.
- Explained to the significant others the drug names as well as the
right route and dosage.
- Informed the significant others about the side effects that may
occur brought by the medication.
- Encouraged the significant others to comply and follow religiously
the right timing in taking the medication.
Exercise/Environment
53
-
7/31/2019 CP Jaundice Chapter VII
24/25
- Instructed significant others to avoid risk factors that may harm
Baby DongHae.
- Encouraged significant others to always keep in mind of the
safety and security of the patient.
Treatment
- Instructed to comply with the physicians prescribed medication
such as the antibiotic to treat infections.
Hygiene
- Instructed significant others to bathe Baby DongHae everyday.
- Advised significant others to change soaked diaper into new one.
Outpatient
- Advised significant others to visit or have a follow up check-up
with the attending physician.
- Advised to call and notify the attending physician for any
abnormalities or complications that may further occur.
Diet
- Encouraged to continue breastfeeding.
54
-
7/31/2019 CP Jaundice Chapter VII
25/25
- Encouraged mother to eat nutritious foods that would help in her
breastfeeding.